SCHEIBLER LUKAS 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 7, 2023
Insider Transaction Report
Form 4
SCHEIBLER LUKAS
See Remarks
Transactions
- Sale
Common Stock
2023-09-06$43.01/sh−1,756$75,526→ 68,299 total
Footnotes (1)
- [F1]This includes 412 shares from 04/30/2023 ESPP purchase.